Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
about
Nonalcoholic Lipid Accumulation and Hepatocyte Malignant TransformationReduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial.Annexin A6 protein is downregulated in human hepatocellular carcinoma.Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.Projections of primary liver cancer to 2030 in 30 countries worldwide.A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes.Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.Obesity and cancer: inflammation bridges the two.NAFLD and diabetes mellitus.Ameliorative effects of glycine in an experimental nonalcoholic steatohepatitis and its correlation between TREM-1 and TREM-2.Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.Focal nodular hyperplasia: our experience of 53 Japanese cases.Using molecular functional networks to manifest connections between obesity and obesity-related diseases.Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues.Lipotoxicity induces hepatic protein inclusions through TBK1-mediated p62/SQSTM1 phosphorylation.Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression.Silibinin Reduces the Impact of Obesity on Invasive Liver Cancer.Sleep Duration and Risk of Liver Cancer in Postmenopausal Women: The Women's Health Initiative Study.Betaine Supplementation Enhances Lipid Metabolism and Improves Insulin Resistance in Mice Fed a High-Fat Diet.Proceedings of the 2017 ASPEN Research Workshop-Gastric Bypass: Role of the Gut.Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma.Eicosapentaenoic acid attenuates obesity-related hepatocellular carcinogenesis.Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer.CFIm25 inhibits hepatocellular carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling pathways.Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma.Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1.Adherence to the Chinese or American Dietary Guidelines is Associated with a Lower Risk of Primary Liver Cancer in China: A Case-Control Study
P2860
Q26746521-FFD1F65C-9725-4B6C-84FB-9911125BED1CQ36757403-8420734A-74F0-458C-84E3-D001B3FAD217Q38291920-67F5C6FD-3401-4CE3-906A-E681C043B422Q38607710-2D834916-1E04-44F9-8F4F-6A3C4876624FQ38634903-2B43B1FF-A02D-4CAD-A6F2-C193C3EE4476Q38718299-484E03BC-EDBF-499C-8C98-9B179BFB7666Q38752448-A200C5CA-5DF6-408B-92CF-48743C5517D0Q38900947-D08B1A3C-5154-432A-96D4-9A1A3CE6E3DCQ38978347-42F0A451-56C2-4CFB-B913-8EBED012F252Q39172928-B0721F15-3558-42D1-AB04-F3131E5078CCQ39363389-A8E75B19-FCC6-4144-A84C-15AAC860559FQ39464803-E540E888-264B-4EB2-8F45-AFA7E867C056Q47111161-FD806B6C-CD28-4365-A599-6BF8E1E6259BQ47129380-2842585A-D586-4B00-A9AC-F9F961F55C72Q47281872-AD1F9B42-1B4E-4182-97BD-92F207F6A701Q47589822-56F6BB3B-F2C0-4FCB-8C36-CAEC9FD9C1BBQ47605867-C7C74B32-C15B-431A-8B7B-6E9341215FE4Q47682816-7A89600A-FE3A-4076-AE33-A6B0EEC3A32EQ49653040-D461CD30-57C1-49B4-9782-8E1D4C0940EAQ50005567-FBA09E4E-395B-45BF-B920-D6D7E3E0C154Q50063376-F9AE6B83-A0CF-4111-A65A-8893E98BAE3AQ50080490-66E7E163-7045-40FC-A1A2-EF5514948DADQ50199746-E9071F18-A396-4858-A166-5633CF97A7E9Q52726205-3534E827-536F-45C3-A870-A2EE7584E94DQ55008075-CAEB8DF8-325F-48DB-8259-957BAE49C6ACQ55237332-A0372E2A-2E37-45E4-A8FD-0F8DDC2D99F5Q58768335-9CA8B021-C28C-4878-828F-68BE5B2840E7
P2860
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
@ast
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
@en
type
label
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
@ast
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
@en
prefLabel
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
@ast
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
@en
P1476
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
@en
P2093
Andrea Marengo
P304
P356
10.1146/ANNUREV-MED-090514-013832
P577
2015-10-14T00:00:00Z